Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
JAMA Dermatology
|
March 30, 2022
Clinical and Serological Characterization of Orf-Induced Immunobullous Disease
Kaan Yilmaz, Stephanie Goletz, Henri H Pas, et al.
Journal of Autoimmunity
|
September 17, 2018
IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid
Lenche Chakievska, Maike M Holtsche, Axel Künstner, et al.
The Journal of Investigative Dermatology
|
September 25, 2024
Anti-Laminin β4 IgG Drives Tissue Damage in Anti-p200 Pemphigoid and Shows Interactions with Laminin α3 and γ1/2 Chains
Manuela Pigors, Stephanie Goletz, Yao Wang, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
August 6, 2025
Clinical and immunopathological spectrum of immunoglobulin M pemphigoid: a multicenter case series
Kaan Yilmaz, Stephanie Goletz, Christoph M Hammers, et al.
Journal of the American Academy of Dermatology
|
November 22, 2023
Laminin β4 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid
Stephanie Goletz, Manuela Pigors, Tina Rastegar Lari, et al.
The Journal of Pathology
|
November 6, 2023
Bullous pemphigoid induced by IgG targeting type XVII collagen non-NC16A/NC15A extracellular domains is driven by Fc gamma receptor- and complement-mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade
Manuela Pigors, Sabrina Patzelt, Niklas Reichhelm, et al.
Journal of the American Academy of Dermatology
|
January 1, 2017
Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases
Nina van Beek, Cornelia Dähnrich, Nora Johannsen, et al.
Frontiers in Immunology
|
October 17, 2022
Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
Saeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, et al.
Frontiers in Immunology
|
December 19, 2022
Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
Saeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, et al.
Biomolecules
|
March 28, 2026
Complement Activation May Drive the Pathogenicity of Anti-α6 and Anti-β4 Integrin Antibodies In Vivo
Gefei Du, Shirin Emtenani, Dennis Niese, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
JAMA Dermatology
|
March 30, 2022
Clinical and Serological Characterization of Orf-Induced Immunobullous Disease
Kaan Yilmaz, Stephanie Goletz, Henri H Pas, et al.
Journal of Autoimmunity
|
September 17, 2018
IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid
Lenche Chakievska, Maike M Holtsche, Axel Künstner, et al.
The Journal of Investigative Dermatology
|
September 25, 2024
Anti-Laminin β4 IgG Drives Tissue Damage in Anti-p200 Pemphigoid and Shows Interactions with Laminin α3 and γ1/2 Chains
Manuela Pigors, Stephanie Goletz, Yao Wang, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
August 6, 2025
Clinical and immunopathological spectrum of immunoglobulin M pemphigoid: a multicenter case series
Kaan Yilmaz, Stephanie Goletz, Christoph M Hammers, et al.
Journal of the American Academy of Dermatology
|
November 22, 2023
Laminin β4 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid
Stephanie Goletz, Manuela Pigors, Tina Rastegar Lari, et al.
The Journal of Pathology
|
November 6, 2023
Bullous pemphigoid induced by IgG targeting type XVII collagen non-NC16A/NC15A extracellular domains is driven by Fc gamma receptor- and complement-mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade
Manuela Pigors, Sabrina Patzelt, Niklas Reichhelm, et al.
Journal of the American Academy of Dermatology
|
January 1, 2017
Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases
Nina van Beek, Cornelia Dähnrich, Nora Johannsen, et al.
Frontiers in Immunology
|
October 17, 2022
Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
Saeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, et al.
Frontiers in Immunology
|
December 19, 2022
Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
Saeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, et al.
Biomolecules
|
March 28, 2026
Complement Activation May Drive the Pathogenicity of Anti-α6 and Anti-β4 Integrin Antibodies In Vivo
Gefei Du, Shirin Emtenani, Dennis Niese, et al.
Page
of 4